A specialized amide intermediate. ComWin supplies this building block for the synthesis of pharmaceutical APIs and fine chemicals.

Semaglutide is a glucagon-like peptide-1 (GLP-1)  receptor agonist developed for the treatment of  type 2 diabetes and chronic weight management. It  works by enhancing glucose-dependent insulin  secretion, reducing glucagon release, slowing  gastric emptying, and increasing...

ComWin supplies high purity Tirzepatide API CAS 2023788-19-2, Tirzepatide is a dual agonist of the glucose-dependent insulinotropic  polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is approved for the treatment of type 2 diabetes. By enhancing insulin secretion, reducing glu...

ComWin supplies high purity Retatrutide API CAS 2381089-83-2, Retatrutide is a novel peptide therapeutic that functions as a triple agonist of the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors(GCG). The combined pharmacological actions of...

Vitamin K1 (Phylloquinone) is a natural fat-soluble vitamin extracted from green plants. It plays an essential role in blood coagulation and bone metabolism by activating key coagulation factors and osteocalcin in the human body.

Ponazuril is a high-quality veterinary active pharmaceutical ingredient. It is widely applied for the prevention and treatment of protozoan diseases in animals, featuring excellent efficacy and stable physical & chemical properties.

Omeprazole is a proton pump inhibitor that has a strong and long-lasting inhibitory effect on gastric acid secretion in animals and humans. Clinically, it is used to treat peptic ulcers, reflux esophagitis, Zollinger-Ellison syndrome, and eradicate Helicobacter pylori (HP).

Cagrilintide is a long-acting amylinanalogue designed. As an agonist ofamylin receptors, it complementsincretin-based therapies by regulatingappetite, delaying gastric emptying,and promoting satiety. Clinical studieshave shown that cagrilintide,particularly in combination with GLP-1receptor agonists...